BRPI0514526A - nutrição infantil estimulatória imune - Google Patents

nutrição infantil estimulatória imune

Info

Publication number
BRPI0514526A
BRPI0514526A BRPI0514526-0A BRPI0514526A BRPI0514526A BR PI0514526 A BRPI0514526 A BR PI0514526A BR PI0514526 A BRPI0514526 A BR PI0514526A BR PI0514526 A BRPI0514526 A BR PI0514526A
Authority
BR
Brazil
Prior art keywords
acid
fatty acids
composition
total fatty
whey
Prior art date
Application number
BRPI0514526-0A
Other languages
English (en)
Inventor
Guenther Boehm
Christopher Beermann
Bernd Stahl
Laura M Rabet
Johan Garssen
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34926246&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0514526(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BRPI0514526A publication Critical patent/BRPI0514526A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)

Abstract

NUTRIçãO INFANTIL ESTIMULATóRIA IMUNE. Refere uma composição nutricional ou farmacêutica, contendo um componente de gordura, um componente de proteína e um componente de carboidrato e compreendendo som de leite e caseína, a dita composição sendo caracterizada pelo fato de que a proporção em peso da caseína para a som de leite é de 1:1 a 1:2,4 e a composição contém: a) pelo menos 3 gramas de arginina por 100 gramas de proteína; b) pelo menos 10% em peso de ácido linoléico, baseado no peso total de ácidos graxas; c) pelo menos 1% em peso de ácido alfa-linoléico, baseado no peso total de ácidos graxos; d) pelo menos um ácido graxa poliinsaturado de cadeia longa, em uma quantidade que excede a 0,1% em peso, baseado no peso total de ácidos graxos, o dito ácido graxo poliinsaturado de cadeia longa sendo selecionado do grupo que consiste de ácido docosahexaenóico, ácido araquidónico e ácido eicosapentaenóico; e) 5 a 25% em peso de pelo menos um ácido graxo poliinsaturado, baseado no peso total de ácido graxo; e f) 2 a 12 gramas de oligossacarídeos indigestos, tendo um grau de polimerização de 2 a 100 por 100 gramas de peso seco da composição. A composição da invenção reduz, entre outras coisas, os riscos pertinentes à fórmulas de alimentação infantis predominantes de som de leite.
BRPI0514526-0A 2004-08-20 2005-08-19 nutrição infantil estimulatória imune BRPI0514526A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04019856A EP1634599A1 (en) 2004-08-20 2004-08-20 Iimmune stimulatory infant nutrition
PCT/EP2005/008999 WO2006018314A2 (en) 2004-08-20 2005-08-19 Immune stimulatory infant nutrition

Publications (1)

Publication Number Publication Date
BRPI0514526A true BRPI0514526A (pt) 2008-06-10

Family

ID=34926246

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0514526-0A BRPI0514526A (pt) 2004-08-20 2005-08-19 nutrição infantil estimulatória imune
BRPI0514498-1A BRPI0514498A (pt) 2004-08-20 2005-08-22 composição nutricional, e, uso da composição nutricional

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0514498-1A BRPI0514498A (pt) 2004-08-20 2005-08-22 composição nutricional, e, uso da composição nutricional

Country Status (15)

Country Link
US (3) US8114441B2 (pt)
EP (3) EP1634599A1 (pt)
JP (2) JP4965444B2 (pt)
CN (3) CN101766228B (pt)
AT (1) ATE427112T1 (pt)
AU (2) AU2005274266B2 (pt)
BR (2) BRPI0514526A (pt)
CA (2) CA2576042C (pt)
DE (1) DE602005013679D1 (pt)
ES (1) ES2322380T3 (pt)
NZ (2) NZ553248A (pt)
PL (1) PL1781307T3 (pt)
RU (2) RU2426549C2 (pt)
UA (1) UA88918C2 (pt)
WO (2) WO2006018314A2 (pt)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
PT1629850E (pt) 2004-08-24 2007-08-14 Nutricia Nv Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
US20060210524A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin care composition
US7749545B2 (en) 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
AU2006251562B2 (en) * 2005-05-23 2012-03-22 Massachusetts Institute Of Technology Compositions containing PUFA and methods of use thereof
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
BRPI0620465A2 (pt) * 2005-12-23 2011-11-16 Nutricia Nv uso de uma composição
PL1800675T4 (pl) * 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
WO2007096148A1 (en) * 2006-02-23 2007-08-30 Lipid Nutrition B.V. Immunoregulation
JP4610499B2 (ja) * 2006-02-27 2011-01-12 ポーラ化成工業株式会社 食品組成物
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
US8691213B2 (en) 2006-08-04 2014-04-08 SHS International Protein free formula
US20080145506A1 (en) * 2006-12-18 2008-06-19 Bodybio, Inc. Food compositions and products containing balanced ratio of essential fatty acids
BRPI0721442A2 (pt) * 2007-03-13 2013-01-15 Nutricia Nv uso de uma composiÇço
WO2008115046A1 (en) * 2007-03-22 2008-09-25 N.V. Nutricia Cereal-based infant nutrition with fibre
BRPI0810138A2 (pt) * 2007-05-18 2014-09-23 Mead Johnson Nutrition Co Suplemento de leite humano líquido acidificado
CN101888793B (zh) * 2007-09-17 2015-01-14 荷兰纽迪希亚公司 具有高能含量的营养配方
US10251899B2 (en) * 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
PL2211629T3 (pl) * 2007-10-19 2020-11-16 Fonterra Co-Operative Group Limited Sposoby podtrzymania albo poprawy wzrostu lub rozwoju kognitywnego
MX2010004820A (es) * 2007-11-01 2010-08-10 Enzymotec Ltd Mezcla lipidica para nutricion infantil.
WO2009057994A1 (en) * 2007-11-02 2009-05-07 N.V. Nutricia Unit dosage for brain health
WO2009075564A1 (en) * 2007-12-10 2009-06-18 N.V. Nutricia Paediatric fibre mixture
AU2008347177B2 (en) 2008-01-04 2014-04-17 Société des Produits Nestlé S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
EP2130440A1 (en) * 2008-06-06 2009-12-09 N.V. Nutricia Inhibiting E. sakazakii growth
BRPI0924051A2 (pt) * 2009-01-19 2015-07-21 Nestec Sa Composição nutricional para lactente
WO2010110649A1 (en) * 2009-03-24 2010-09-30 N.V. Nutricia Stage 1 and stage 2 infant formula
WO2010147456A1 (en) * 2009-06-19 2010-12-23 N.V. Nutricia Inhibition of nfk-b mediated virus replication with specific oligosaccharides
US20130196934A1 (en) * 2010-01-21 2013-08-01 Paul Bradley Addis Composition for perinatal and neonatal stroke
NZ623342A (en) 2010-04-26 2014-12-24 Enzymotec Ltd Methods and lipid compositions for promoting development of gut flora
JP5996837B2 (ja) * 2010-05-28 2016-09-21 小林製薬株式会社 インフルエンザウイルスの感染抑制剤
CN101978841B (zh) * 2010-08-31 2013-04-10 浙江贝因美科工贸股份有限公司 一种抗蛋白过敏及营养婴儿配方奶粉
WO2012044155A1 (en) * 2010-09-28 2012-04-05 N.V. Nutricia Fat composition for programming immune response
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
ES2674430T3 (es) 2010-12-29 2018-06-29 Abbott Laboratories Producto nutricional para mejorar la tolerancia, digestión y absorción de nutrientes liposolubles en un lactante, niño pequeño o niño
MY166945A (en) 2010-12-31 2018-07-25 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
ES2667393T3 (es) 2010-12-31 2018-05-10 Abbott Laboratories Oligosacáridos de leche humana para modular inflamación
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
CA2822490C (en) 2010-12-31 2020-03-31 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
CN107019701B (zh) 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
US8795746B2 (en) * 2011-02-16 2014-08-05 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
FI124323B (fi) * 2011-02-18 2014-06-30 Valio Oy Maitopohjainen tuote ja menetelmä sen valmistamiseksi
WO2012133198A1 (ja) * 2011-03-25 2012-10-04 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物
JP5837315B2 (ja) * 2011-03-25 2015-12-24 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物
WO2012177118A1 (en) 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
EP2734210B1 (en) 2011-07-22 2017-11-22 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CA2846603A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
AU2014240730B2 (en) 2013-03-27 2018-11-15 Nutritional Growth Solutions Ltd Nutritional supplement for growth enhancement
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
DE202013008190U1 (de) 2013-09-17 2013-12-05 Pg Naturpharma Gmbh Zubereitung und deren Verwendung bei atopischer Dermatitis
EP2857410A1 (en) * 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
EP3082827A1 (en) * 2013-11-15 2016-10-26 Nestec S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section
US20150157048A1 (en) * 2013-12-11 2015-06-11 Mead Johnson Nutrition Company Nutritional compositions containing stearidonic acid and uses thereof
WO2015154260A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them.
WO2015154256A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and,nutritional systems comprising them
WO2015154251A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them.
WO2015154263A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
WO2015154265A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
WO2015154254A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
WO2015154259A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
WO2015154257A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and, nutritional systems comprising them
WO2016007778A1 (en) 2014-07-09 2016-01-14 Midori Usa, Inc. Oligosaccharide compositions and methods for producing thereof
FR3029114B1 (fr) * 2014-12-01 2017-01-13 United Pharmaceuticals Composition nutritionnelle infantile dans le traitement de la dermatite atopique et de ses symptomes
EP4209130A1 (en) 2015-01-26 2023-07-12 DSM Nutritional Products, LLC Oligosaccharide compositions for use animal feed and methods of producing thereof
CA2973617A1 (en) 2015-01-26 2016-08-04 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
EP3964234A1 (en) * 2015-04-23 2022-03-09 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
CN105231461A (zh) * 2015-10-30 2016-01-13 中营康园（北京）科技有限公司 一种提高机体免疫力的营养组合物及其应用
ES2638195B1 (es) * 2016-04-18 2018-08-02 Bioiberica, S.A. Composiciones para la piel
JP7576375B2 (ja) 2017-11-03 2024-10-31 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン調製物及び高アンモニア血症のための使用方法
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
WO2020130803A1 (en) 2018-12-21 2020-06-25 N.V. Nutricia Protein compositions with high isoelectric proteins
US12005083B1 (en) 2019-06-24 2024-06-11 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US11849747B1 (en) 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
CN112933104B (zh) * 2021-02-02 2021-12-14 陈玉松 核苷酸的新用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61192245A (ja) * 1985-02-21 1986-08-26 Snow Brand Milk Prod Co Ltd アルギニン配合粉乳
AU769645B2 (en) * 1987-05-29 2004-01-29 Abbott Laboratories Nourishing products enriched with nucleosides and/or nucleotides for infants and adults and processes for their preparation
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
AU651626B2 (en) * 1990-10-24 1994-07-28 Nestec S.A. Medical foods having soluble fiber
ES2157898T3 (es) 1991-01-24 2001-09-01 Martek Corp Aceites microbianos y usos de los mismos.
US5472952A (en) 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
DE4344342C2 (de) 1993-12-23 1996-08-08 Milupa Ag Molkenprotein-dominante Säuglingsnahrung
JP3419897B2 (ja) * 1994-07-22 2003-06-23 明治乳業株式会社 低アレルギー性調製乳
JP4034364B2 (ja) * 1994-10-11 2008-01-16 雪印乳業株式会社 抗アレルギー剤
EP0756828B2 (en) * 1995-08-04 2010-09-22 N.V. Nutricia Nutritional composition containing fibres
US5792501A (en) * 1996-04-15 1998-08-11 The Iams Company Queen's milk replacer
US5780081A (en) * 1996-10-28 1998-07-14 Nestec S.A. Fortification of food with calcium and process of making
JPH10262607A (ja) * 1997-03-28 1998-10-06 Snow Brand Milk Prod Co Ltd 乳幼児用栄養組成物
IL132148A0 (en) 1997-04-11 2001-03-19 Calgene Llc Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
FR2781673B1 (fr) * 1998-07-28 2001-09-28 Univ Picardie Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6245379B1 (en) * 1998-09-30 2001-06-12 The Iams Company Method of administering a milk substitute to critical care animals
CA2371696C (en) * 1999-04-29 2005-11-15 Societe Des Produits Nestle S.A. Composition for an infant formula having a low threonine content
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
DE10006989A1 (de) 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
US20040143013A1 (en) 2000-02-28 2004-07-22 Bristol-Myers Squibb Company Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
DE10057976B4 (de) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6511696B2 (en) * 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
US6623954B1 (en) 2002-05-28 2003-09-23 Neose Technologies, Inc. Process for removal of phosphorous from a dairy stream
DK1531832T3 (da) 2002-06-28 2009-07-27 Glykos Finland Oy Terapeutiske sammensætninger til anvendelse ved profylakse eller behandling af diarré
ES2781848T3 (es) 2003-10-24 2020-09-08 Nutricia Nv Oligosacáridos inmunomoduladores

Also Published As

Publication number Publication date
EP1781307A2 (en) 2007-05-09
JP2008510697A (ja) 2008-04-10
RU2007110173A (ru) 2008-09-27
NZ553299A (en) 2010-09-30
WO2006019300A2 (en) 2006-02-23
EP1781306A2 (en) 2007-05-09
WO2006018314A2 (en) 2006-02-23
JP2008510689A (ja) 2008-04-10
CA2576042A1 (en) 2006-02-23
AU2005273099A1 (en) 2006-02-23
CN101039686A (zh) 2007-09-19
JP4965444B2 (ja) 2012-07-04
WO2006018314A3 (en) 2006-06-29
AU2005274266B2 (en) 2011-03-10
EP1781307B1 (en) 2009-04-01
US8580316B2 (en) 2013-11-12
WO2006019300A3 (en) 2006-06-01
US20080125346A1 (en) 2008-05-29
PL1781307T3 (pl) 2009-08-31
ATE427112T1 (de) 2009-04-15
ES2322380T3 (es) 2009-06-19
CA2577698A1 (en) 2006-02-23
AU2005274266A1 (en) 2006-02-23
AU2005273099B2 (en) 2011-08-18
RU2007110174A (ru) 2008-09-27
BRPI0514498A (pt) 2008-06-10
CN101766228A (zh) 2010-07-07
NZ553248A (en) 2009-12-24
DE602005013679D1 (de) 2009-05-14
RU2426549C2 (ru) 2011-08-20
CN101048167A (zh) 2007-10-03
UA88918C2 (ru) 2009-12-10
EP1634599A1 (en) 2006-03-15
US20120195975A1 (en) 2012-08-02
RU2404785C2 (ru) 2010-11-27
CN101766228B (zh) 2013-05-08
US20100136134A1 (en) 2010-06-03
US8114441B2 (en) 2012-02-14
CA2576042C (en) 2017-07-04

Similar Documents

Publication Publication Date Title
PL1781307T3 (pl) Immunostymulująca odżywka dla niemowląt
CA2069600C (en) Fatty acid compositions
RU2010129984A (ru) Композиции питательного порошка и детской питательной смеси (варианты)
Moriguchi et al. Effects of an n-3-deficient diet on brain, retina, and liver fatty acyl composition in artificially reared rats
DK1809125T3 (da) Næringsmiddel, der indeholder en fedtblanding
ATE361066T1 (de) Polyungesättigen fettsäuren nährungsergänzung
WO2007070611A3 (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
ES2022165B3 (es) Nueva mezcla de grasa rica en poliacidos y su empleo en la fabricacion de alimentos de lactantes
MX281182B (es) Produccion y uso de una fraccion rica en lipidos polares, que contienen acidos grasos altamente insaturados omega-3 y/u omega-6, procedentes de microbios, de semillas de plantas y de organismos marinos geneticamente modificados.
JP2006501840A5 (pt)
WO2008147562A3 (en) Dietary formulations and methods for treatment of inflammation and other disorders
CN1838888A (zh) 婴儿或第二阶段配方奶
FR2714574B1 (fr) Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
JP2008519796A5 (pt)
González et al. In time: importance of omega 3 in children’s nutrition
RU2010119238A (ru) Состав для улучшения функции желудочно-кишечного тракта
ES2538037T3 (es) Emulsiones nutricionales de viscosidad inducida
RU2013105287A (ru) Комплект учитывающих возрастные особенности питательных смесей с оптимальным содержанием жира
ATE454820T1 (de) Neuartige fettpulver
DK1027831T3 (da) Stabiliseret fedtstofsammensætning, fremgangsmåde til fremstilling deraf og ernæringsprodukt indeholdende denne
WO2003043445A3 (en) Processed baby food with unsaturated fatty acids and/or nucleotides
RU2008117138A (ru) Способы и композиции для улучшения когнитивной функции
PL1656034T3 (pl) Sole wapniowe kwasów tłuszczowych trans i polinienasyconych kwasów tłuszczowych zabezpieczone przed rozkładem w żwaczu
KR101722516B1 (ko) 오메가 밸런스 육계용 사료 조성물
DE50202162D1 (de) Diätetisches Lebensmittel

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements